1. In vitro and In vivo Antitumor Effects of the Dual Insulin-Like Growth Factor-I/Insulin Receptor Inhibitor, BMS-554417
   Paul Haluska et al, 2006, Cancer Research CrossRef
2. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo
   Qun-sheng Ji et al, 2007, Molecular Cancer Therapeutics CrossRef
3. Spontaneous Expression of Embryonic Factors and p53 Point Mutations in Aged Mesenchymal Stem Cells: A Model of Age-Related Tumorigenesis In Mice
   Hanchen Li et al, 2007, Cancer Research CrossRef
4. Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy
   Eirini-Maria Giatagana et al, 2022, Cancers CrossRef